|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q90221506
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000209.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q90221506
|
|
024
|
|
|
‡a
0000-0001-5480-431X
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q90221506
|
|
100
|
0 |
|
‡a
Hanwen Wang
‡c
researcher (ORCID 0000-0001-5480-431X)
‡9
en
|
|
400
|
0 |
|
‡a
Hanwen Wang
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's Conducting a Virtual Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative Systems Pharmacology Model With an Epigenetic Modulator and Immune Checkpoint Inhibitors
|
|
670
|
|
|
‡a
Author's In silico simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model.
|
|
670
|
|
|
‡a
Author's Simulations of tumor growth and response to immunotherapy by coupling a spatial agent-based model with a whole-patient quantitative systems pharmacology model
|
|
909
|
|
|
‡a
(orcid) 000000015480431x
‡9
1
|
|
919
|
|
|
‡a
conductingavirtualclinicaltrialinher2negativebreastcancerusingaquantitativesystemspharmacologymodelwithanepigeneticmodulatorandimmunecheckpointinhibitors
‡A
Conducting a Virtual Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative Systems Pharmacology Model With an Epigenetic Modulator and Immune Checkpoint Inhibitors
‡9
1
|
|
919
|
|
|
‡a
insilicosimulationofaclinicaltrialwithantictla4andantipdl1immunotherapiesinmetastaticbreastcancerusingasystemspharmacologymodel
‡A
In silico simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model.
‡9
1
|
|
919
|
|
|
‡a
simulationsoftumorgrowthandresponsetoimmunotherapybycouplingaspatialagentbasedmodelwithawholepatientquantitativesystemspharmacologymodel
‡A
Simulations of tumor growth and response to immunotherapy by coupling a spatial agent-based model with a whole-patient quantitative systems pharmacology model
‡9
1
|
|
996
|
|
|
‡2
ISNI|0000000047014056
|
|
996
|
|
|
‡2
NSK|000274444
|
|
996
|
|
|
‡2
NTA|344701581
|
|
996
|
|
|
‡2
DNB|1148111727
|
|
996
|
|
|
‡2
NSK|000595891
|
|
996
|
|
|
‡2
NTA|364154659
|
|
996
|
|
|
‡2
LC|nb2023003044
|
|
996
|
|
|
‡2
PLWABN|9810590627605606
|
|
996
|
|
|
‡2
NSK|000708662
|
|
996
|
|
|
‡2
PLWABN|9812073744605606
|
|
996
|
|
|
‡2
NTA|364154063
|
|
996
|
|
|
‡2
DNB|1269706152
|
|
996
|
|
|
‡2
PLWABN|9811557967105606
|
|
996
|
|
|
‡2
NSK|000261043
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
